TERRI SCAMARDO: Open Payments
NPI 1609204247 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 10 payments from 9 companies in 2025. Trend: 2023 $717 · 2024 $844 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $190 |
| Madrigal Pharmaceuticals | 1 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| BTG International Inc. | 1 | $103 |
| Novo Nordisk Inc | 1 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $80 |
| Paratek Pharmaceuticals, Inc. | 1 | $79 |
| Gilead Sciences, Inc. | 1 | $73 |
Products named: REZDIFFRA, TZIELD, KRYSTEXXA, AUSTEDO XR, CroFab, Wegovy, Kerendia, NUZYRA.
Industry payments across TX — which companies pay providers there.
